Omnibus Blocks Closing FDA’s 13 Field Labs, Boosts Safety Programs
This article was originally published in The Tan Sheet
Executive Summary
The $555 billion omnibus appropriations for fiscal 2008 prohibits closing or consolidating any of FDA's field laboratories while allowing the agency to go full speed ahead establishing safety programs authorized by FDA reauthorization legislation
You may also be interested in...
When Reagan-Udall Foundation Gets Started, Funding Is First On To-Do List
The FDA Amendments Act created an abundance of oversight functions to organize in the broad new powers it authorized to FDA for ensuring drug safety, but the act also provides the agency with an outside partner - the Reagan-Udall Foundation
When Reagan-Udall Foundation Gets Started, Funding Is First On To-Do List
The FDA Amendments Act created an abundance of oversight functions to organize in the broad new powers it authorized to FDA for ensuring drug safety, but the act also provides the agency with an outside partner - the Reagan-Udall Foundation
When Reagan-Udall Foundation Gets Started, Funding Is First On To-Do List
The FDA Amendments Act created an abundance of oversight functions to organize in the broad new powers it authorized to FDA for ensuring drug safety, but the act also provides the agency with an outside partner - the Reagan-Udall Foundation